Elsevier

World Neurosurgery

Volume 86, February 2016, Pages 168-172
World Neurosurgery

Original Article
Can a Minimal Clinically Important Difference Be Achieved in Elderly Patients with Adult Spinal Deformity Who Undergo Minimally Invasive Spinal Surgery?

https://doi.org/10.1016/j.wneu.2015.09.072Get rights and content

Background

Older age has been considered a relative contraindication to complex spinal procedures. Minimally invasive surgery (MIS) techniques to treat patients with adult spinal deformity (ASD) have emerged with the potential benefit of decreased approach-related morbidity.

Objective

To determine whether a minimal clinically important difference (MCID) could be achieved in patients ages ≥65 years with ASD who underwent MIS.

Methods

Multicenter database of patients who underwent MIS for ASD was queried. Outcome metrics assessed were Oswestry Disability Index (ODI) and visual analog scale (VAS) scores for back and leg pain. On the basis of published reports, MCID was defined as a positive change of 12.8 ODI, 1.2 VAS back pain, and 1.6 VAS leg pain.

Results

Forty-two patients were identified. Mean age was 70.3 years; 31 (73.8%) were women. Preoperatively, mean coronal curve, pelvic tilt, pelvic incidence to lumbar lordosis mismatch, and sagittal vertical axis were 35°, 24.6°, 14.2°, and 4.7 cm, respectively. Postoperatively, mean coronal curve, pelvic tilt, pelvic incidence to lumbar lordosis, and sagittal vertical axis were 18°, 25.4°, 11.9°, and 4.9 cm, respectively. A mean of 5.0 levels was treated posteriorly, and a mean of 4.0 interbody fusions was performed. Mean ODI improved from 47.1 to 25.1. Mean VAS back and leg pain scores improved from 6.8 and 5.9 to 2.7 and 2.7, respectively. Mean follow-up was 32.1 months. For ODI, 64.3% of patients achieved MCID. For VAS back and leg pain, 82.9% and 72.2%, respectively, reached MCID.

Conclusions

MCID represents the threshold at which patients feel a meaningful clinical improvement has occurred. Our study results suggest that the majority of elderly patients with modest ASD can achieve MCID with MIS.

Introduction

Older age has long been considered a relative contraindication to spinal fusion, given the concern for possible increased morbidity and poorer outcomes compared with decompression alone. In recent years, however, studies have shown that elderly patients older than 65 years of age can derive significant benefit from decompression and fusion for degenerative spinal disease without significantly increased morbidity.1, 2, 3 These studies have focused primarily on short segment fusions for degenerative conditions such as stenosis and spondylolisthesis.

Spinal deformity also can be a cause of significant pain and disability in the elderly patient that often requires more complex, multilevel spinal surgery to treat appropriately. Reports regarding outcomes involving the elderly patients with adult spinal deformity (ASD) who undergo spinal surgery are scarce, although in 1 study Daubs et al.4 showed that significant clinical improvement could be obtained in patients ages 60 years and older. Recently, minimally invasive surgery (MIS) approaches have been used to treat patients with ASD, with the potential benefit of decreased approach-related morbidity.5, 6, 7, 8 Similar to the relative paucity of literature focusing on the elderly and traditional open spinal surgery, there has been little investigation involving the elderly with ASD who undergo MIS. The objective of this study was to determine whether a minimal clinically important difference (MCID) could be achieved in patients 65 years of age and older who underwent MIS for ASD.

Section snippets

Methods

In this study, each participating site received institutional review board approval before submitting data to create a multicenter database of patients who underwent MIS for ASD. Inclusion criteria for this database were a diagnosis of ASD with at least 1 of the following radiographic parameters: coronal curve (CC) ≥20°, sagittal vertical axis (SVA) >5 cm, pelvic tilt (PT) >25°, or thoracic kyphosis >60°. A total of 190 patients were entered into the database, which was composed of those who

Results

Mean age was 70.3 (standard deviation [SD], 4.9) years, and 31 (73.8%) of the patients were female. A mean of 4.0 (SD, 1.5) interbody fusions were performed, and a mean of 5.0 (SD, 2.8) levels were treated posteriorly. Five of the 42 patients had undergone LLIF without posterior instrumentation. Mean estimated blood loss was 507.7 mL (SD, 537.3), and mean length of stay was 7.5 days (SD, 4.1). Complications occurred in 14 (33.3%) patients. Eight patients had at least 1 major complication, and 7

Discussion

In the current study, the large majority of elderly patients undergoing MIS for ASD achieved the MCID in key patient-reported outcome (PRO) measures. PROs are now used commonly to determine the impact of spinal surgery. The ODI is a validated instrument for assessing functional outcome, whereas the VAS instrument is used widely to assess pain. Although the ODI and VAS provide an objective means of recording a change in patient status after spinal surgery, the numerical values have no direct

Conclusions

The MCID represents the threshold at which patients perceive that a meaningful clinical improvement has occurred after treatment. The results of this study suggest that the majority of elderly patients with ASD, who primarily have CCs, can achieve MCID with MIS. Further studies determining MCID for ASD patients are needed, as are investigations of MCID involving elderly patients with more significant sagittal plane deformities.

References (14)

There are more references available in the full text version of this article.

Cited by (29)

  • The role of less invasive surgery in the treatment of adolescent idiopathic scoliosis and adult spinal deformity

    2021, Orthopaedics and Trauma
    Citation Excerpt :

    A PubMed/Medline search from 2015 to 2020 using ‘MISS’, ‘adult spine’ and ‘deformity’ as key words was able to isolate 68 papers. Publications by the International Spine Study Group (ISSG) suggested that the majority of elderly patients with modest ASD can achieve MCID (positive changes on ODI and VAS) with MIS.12 Both hybrid and circumferential MIS (cMIS) approaches resulted in clinical improvement, as evidenced by decreased ODI and VAS pain scores.

  • Use of robotics and novel technologies in spine surgery in elderly patients

    2020, Seminars in Spine Surgery
    Citation Excerpt :

    A review by Shamji et al. found that minimally invasive techniques, such as decompression alone, decompression and interbody fusion, and deformity correction, are technically feasible and safe in elderly individuals.30 Several other studies describe the safety and efficacy of MIS approaches for lumbar interbody fusion and spine deformity in elderly patients.31,32,33,34 Robotic assistance allows the surgeon to plan trajectories and place pedicle screws without the extensive muscle and soft tissue dissection needed for open surgery.

  • Is it sufficient to treat adult lumbar spinal deformity using anterior lumbar interbody fusion with percutaneous pedicle screw fixation?

    2020, Journal of Clinical Neuroscience
    Citation Excerpt :

    Patients with adult degenerative scoliosis include elderly individuals. The majority of elderly patients with modest degenerative scoliosis achieved minimal clinically significant differences in outcome following MIS.[25] Park et al.[26] also reported another comparative study of hybrid (HYB) and circumferential MIS (cMIS) approaches for the treatment of adult spinal deformity.

View all citing articles on Scopus

Conflict of interest statement: The authors report the following: N.A.: consultant for Medtronic, Globus Medical, and Baxano Surgical; direct stock ownership in Globus Medical and Medtronic; receiving royalties from Medtronic, Globus Medical, NuVasive, and Baxano Surgical. V.D.: consultant for NuVasive, Guidepoint, and Stryker’ A.S.K.: consultant for NuVasive; receiving royalties from Lanx. F.L.M.: consultant for Globus Medical and Biomet; patent holder with Globus Medical; receiving nonstudy-related clinical/research support from Globus Medical. P.V.M.: direct stock ownership in Spinicity; receiving royalties from DePuy Spine, Quality Medical Publisher, and Thieme Publishers; received honoraria from Globus Medical. G.M.M.: consultant for and receiving royalties from NuVasive and K2M. D.O.O.: receiving royalties from Lanx. P.P.: consultant for Medtronic, Globus Medical, and Biomet; receiving royalties from Globus Medical; receiving nonstudy-related clinical/research support from Orthofix, Blue Care Blue Cross Foundation. C.I.S.: consultant for Biomet, Globus Medical, Medtronic, NuVasive, and Stryker; patent holder with Biomet and Medtronic; receiving royalties from Biomet and Medtronic. J.S.U.: consultant for NuVasive. M.Y.W.: consultant for Aesculap Spine and DePuy Spine; patent holder with DePuy Spine.

View full text